# A Sourcing Study to Collect Human Blood Samples From Healthy Adults

> **NCT03493919** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1021 (actual)

## Conditions studied

- Meningitis, Meningococcal

## Interventions

- **BIOLOGICAL:** rMenB+OMV NZ vaccine
- **BIOLOGICAL:** Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY)

## Key facts

- **NCT ID:** NCT03493919
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-08
- **Primary completion:** 2022-05-27
- **Final completion:** 2022-05-27
- **Target enrollment:** 1021 (ACTUAL)
- **Last updated:** 2023-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493919, "A Sourcing Study to Collect Human Blood Samples From Healthy Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03493919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*